유전자 패널 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Gene Panel Market size is expected to reach USD 21.10 Billion in 2034 from USD 4.81 Billion (2025) growing at a CAGR of 17.86% during 2026-2034.

The Global Gene Panel Market is experiencing accelerated growth driven by the rapid expansion of precision medicine and targeted therapies. Gene panels allow simultaneous analysis of multiple genes associated with specific diseases, particularly in oncology, cardiology, and rare genetic disorders. Increasing cancer prevalence worldwide has significantly boosted demand for comprehensive tumor profiling. Healthcare providers are adopting gene panels to improve diagnostic accuracy and treatment customization. Technological advancements in next-generation sequencing (NGS) platforms are enhancing speed, scalability, and cost-efficiency.

Rising awareness about inherited disorders and preventive genetic screening is further strengthening market growth. Hospitals and specialized diagnostic laboratories are expanding molecular testing capabilities to meet growing patient demand. Pharmaceutical companies are increasingly using gene panels in clinical trials to identify suitable patient populations for targeted drugs. Expanding collaborations between biotech firms and research institutes are accelerating innovation. Additionally, supportive reimbursement policies in developed economies are encouraging broader adoption of genetic testing services.

The market is also benefiting from advancements in bioinformatics and data analytics, which improve interpretation of complex genomic data. Cloud-based genomic databases enable secure data sharing and large-scale research initiatives. The decreasing cost of sequencing technologies is making gene panel testing more accessible in emerging markets. Growing integration of artificial intelligence in genomic analysis is expected to enhance predictive capabilities. Regulatory approvals for companion diagnostics are further driving demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Services

• Test Kits
• Testing Services

By Technique

• Amplicon Based Approach
• Hybridization Based Approach

By Design

• Predesigned Gene Panel
• Customized Gene Panel

By End Use

• Academic & Research Institutes
• Hospital & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies

By Application

• Cancer Risk Assessment
• Diagnosis of Congenital Diseases
• Pharmacogenetics
• Other Applications

COMPANIES PROFILED

• Agilent Technologies, Illumina Inc, Qiagen Inc, Eurofins Genomics, Thermo Fisher Scientific, Foundation Medicine Inc, Guardant Health Inc, Myriad Genetic Laboratories Inc, Cepheid, BioRad Laboratories Inc, Personalis
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENE PANEL MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENE PANEL MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technique
• 5.2. Amplicon Based Approach Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hybridization Based Approach Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENE PANEL MARKET: BY DESIGN 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Design
• 6.2. Predesigned Gene Panel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Customized Gene Panel Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENE PANEL MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospital & Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENE PANEL MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Cancer Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Diagnosis of Congenital Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Pharmacogenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL GENE PANEL MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Services
  • 9.2.2 By Technique
  • 9.2.3 By Design
  • 9.2.4 By End Use
  • 9.2.5 By Application
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Services
  • 9.3.2 By Technique
  • 9.3.3 By Design
  • 9.3.4 By End Use
  • 9.3.5 By Application
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Services
  • 9.4.2 By Technique
  • 9.4.3 By Design
  • 9.4.4 By End Use
  • 9.4.5 By Application
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Services
  • 9.5.2 By Technique
  • 9.5.3 By Design
  • 9.5.4 By End Use
  • 9.5.5 By Application
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Services
  • 9.6.2 By Technique
  • 9.6.3 By Design
  • 9.6.4 By End Use
  • 9.6.5 By Application
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL GENE PANEL INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies
  • 11.2.2 Illumina Inc
  • 11.2.3 Qiagen Inc
  • 11.2.4 Eurofins Genomics
  • 11.2.5 Thermo Fisher Scientific
  • 11.2.6 Foundation Medicine Inc
  • 11.2.7 Guardant Health Inc
  • 11.2.8 Myriad Genetic Laboratories Inc
  • 11.2.9 Cepheid
  • 11.2.10 Bio-Rad Laboratories Inc
  • 11.2.11 Personalis